Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 9363 | 30.12 |
09:33 ET | 2200 | 30.055 |
09:35 ET | 2837 | 30.14 |
09:37 ET | 3061 | 29.95 |
09:39 ET | 1700 | 30.1 |
09:42 ET | 5833 | 30.03 |
09:44 ET | 2316 | 30.16 |
09:46 ET | 2370 | 30.13 |
09:48 ET | 7931 | 30.2 |
09:50 ET | 7036 | 30.25 |
09:51 ET | 2984 | 30.245 |
09:53 ET | 987 | 30.225 |
09:55 ET | 600 | 30.275 |
09:57 ET | 927 | 30.27 |
10:00 ET | 2490 | 30.21 |
10:02 ET | 1265 | 30.22 |
10:04 ET | 2924 | 30.165 |
10:06 ET | 1003 | 30.16 |
10:08 ET | 1000 | 30.09 |
10:09 ET | 3861 | 30.2 |
10:11 ET | 21453 | 30.15 |
10:15 ET | 525 | 30.12 |
10:18 ET | 4602 | 30.14 |
10:20 ET | 4833 | 30.22 |
10:22 ET | 3021 | 30.21 |
10:24 ET | 457 | 30.21 |
10:26 ET | 4077 | 30.16 |
10:27 ET | 4277 | 30.01 |
10:29 ET | 4670 | 29.94 |
10:31 ET | 1951 | 29.96 |
10:33 ET | 4125 | 30.03 |
10:36 ET | 3830 | 29.99 |
10:38 ET | 7134 | 30.03 |
10:40 ET | 1100 | 30.04 |
10:42 ET | 1418 | 30.035 |
10:44 ET | 800 | 30.035 |
10:45 ET | 7978 | 29.985 |
10:47 ET | 721 | 29.98 |
10:49 ET | 4605 | 29.99 |
10:51 ET | 2212 | 30.03 |
10:54 ET | 1404 | 29.995 |
10:56 ET | 2446 | 29.995 |
10:58 ET | 8834 | 29.97 |
11:00 ET | 2792 | 29.96 |
11:02 ET | 2310 | 29.87 |
11:03 ET | 2762 | 29.73 |
11:05 ET | 800 | 29.775 |
11:07 ET | 1784 | 29.745 |
11:09 ET | 4281 | 29.75 |
11:12 ET | 700 | 29.75 |
11:14 ET | 2580 | 29.75 |
11:16 ET | 400 | 29.75 |
11:18 ET | 3900 | 29.75 |
11:20 ET | 3282 | 29.755 |
11:21 ET | 8313 | 29.8 |
11:23 ET | 2750 | 29.78 |
11:25 ET | 6570 | 29.72 |
11:27 ET | 4999 | 29.75 |
11:30 ET | 921 | 29.74 |
11:32 ET | 804 | 29.78 |
11:34 ET | 4805 | 29.79 |
11:36 ET | 400 | 29.79 |
11:38 ET | 11419 | 29.75 |
11:39 ET | 300 | 29.73 |
11:41 ET | 1544 | 29.74 |
11:43 ET | 1213 | 29.73 |
11:45 ET | 1037 | 29.7 |
11:48 ET | 800 | 29.68 |
11:50 ET | 1875 | 29.67 |
11:52 ET | 5617 | 29.645 |
11:54 ET | 400 | 29.645 |
11:56 ET | 526 | 29.645 |
11:57 ET | 4737 | 29.68741 |
11:59 ET | 1274 | 29.67 |
12:01 ET | 1466 | 29.66 |
12:03 ET | 3424 | 29.67 |
12:06 ET | 1881 | 29.7 |
12:08 ET | 443 | 29.72 |
12:10 ET | 811 | 29.735 |
12:12 ET | 3636 | 29.71 |
12:14 ET | 820 | 29.68 |
12:15 ET | 300 | 29.69 |
12:17 ET | 2087 | 29.66 |
12:19 ET | 622 | 29.67 |
12:21 ET | 830 | 29.66 |
12:24 ET | 613 | 29.67 |
12:26 ET | 3999 | 29.68 |
12:28 ET | 1012 | 29.67 |
12:30 ET | 2466 | 29.635 |
12:32 ET | 1366 | 29.635 |
12:33 ET | 1550 | 29.64 |
12:35 ET | 1384 | 29.64 |
12:37 ET | 1107 | 29.64 |
12:39 ET | 900 | 29.66 |
12:42 ET | 3281 | 29.73 |
12:44 ET | 100 | 29.71 |
12:46 ET | 134397 | 29.75 |
12:48 ET | 6725 | 29.72 |
12:50 ET | 4300 | 29.675 |
12:51 ET | 6502 | 29.57 |
12:53 ET | 800 | 29.615 |
12:55 ET | 1448 | 29.61 |
12:57 ET | 2146 | 29.6 |
01:00 ET | 2610 | 29.62 |
01:02 ET | 3332 | 29.595 |
01:04 ET | 761 | 29.62 |
01:06 ET | 1488 | 29.65 |
01:08 ET | 868 | 29.66 |
01:09 ET | 948 | 29.6598 |
01:11 ET | 700 | 29.64 |
01:13 ET | 3189 | 29.59 |
01:15 ET | 1000 | 29.605 |
01:18 ET | 1412 | 29.62 |
01:20 ET | 555 | 29.6 |
01:22 ET | 2765 | 29.61 |
01:24 ET | 1026 | 29.605 |
01:26 ET | 3027 | 29.6 |
01:27 ET | 3213 | 29.59 |
01:29 ET | 900 | 29.61 |
01:31 ET | 2211 | 29.64 |
01:33 ET | 600 | 29.64 |
01:36 ET | 1694 | 29.66 |
01:38 ET | 9015 | 29.69 |
01:40 ET | 200 | 29.69 |
01:42 ET | 600 | 29.69 |
01:44 ET | 1000 | 29.68 |
01:45 ET | 1300 | 29.69 |
01:47 ET | 1589 | 29.67 |
01:49 ET | 1614 | 29.66 |
01:51 ET | 2762 | 29.66 |
01:54 ET | 3698 | 29.66 |
01:56 ET | 200 | 29.67 |
01:58 ET | 1857 | 29.68 |
02:00 ET | 3765 | 29.65 |
02:02 ET | 700 | 29.66 |
02:03 ET | 900 | 29.675 |
02:05 ET | 1110 | 29.67 |
02:07 ET | 400 | 29.67 |
02:09 ET | 1285 | 29.68 |
02:12 ET | 2960 | 29.605 |
02:14 ET | 800 | 29.59 |
02:16 ET | 1638 | 29.59 |
02:18 ET | 2176 | 29.58 |
02:20 ET | 1075 | 29.54 |
02:21 ET | 1927 | 29.51 |
02:23 ET | 1800 | 29.49 |
02:25 ET | 2361 | 29.46 |
02:27 ET | 2038 | 29.48 |
02:30 ET | 1160 | 29.475 |
02:32 ET | 800 | 29.48 |
02:34 ET | 712 | 29.47 |
02:36 ET | 1500 | 29.45 |
02:38 ET | 904 | 29.45 |
02:39 ET | 1755 | 29.46 |
02:41 ET | 1838 | 29.44 |
02:43 ET | 2200 | 29.455 |
02:45 ET | 1884 | 29.395 |
02:48 ET | 500 | 29.4 |
02:50 ET | 4863 | 29.41 |
02:52 ET | 1622 | 29.385 |
02:54 ET | 1277 | 29.4 |
02:56 ET | 4424 | 29.405 |
02:57 ET | 3083 | 29.425 |
02:59 ET | 908 | 29.415 |
03:01 ET | 13141 | 29.4 |
03:03 ET | 3027 | 29.4 |
03:06 ET | 4471 | 29.4 |
03:08 ET | 2343 | 29.4 |
03:10 ET | 3317 | 29.37 |
03:12 ET | 1289 | 29.36 |
03:14 ET | 5563 | 29.365 |
03:15 ET | 2940 | 29.34 |
03:17 ET | 3054 | 29.34 |
03:19 ET | 1539 | 29.32 |
03:21 ET | 3635 | 29.3 |
03:24 ET | 3506 | 29.3 |
03:26 ET | 3668 | 29.27 |
03:28 ET | 1996 | 29.24 |
03:30 ET | 3964 | 29.24 |
03:32 ET | 6644 | 29.26 |
03:33 ET | 7074 | 29.275 |
03:35 ET | 4179 | 29.265 |
03:37 ET | 2830 | 29.265 |
03:39 ET | 6650 | 29.25 |
03:42 ET | 5173 | 29.23 |
03:44 ET | 6767 | 29.2 |
03:46 ET | 7934 | 29.22 |
03:48 ET | 10792 | 29.215 |
03:50 ET | 12048 | 29.215 |
03:51 ET | 8500 | 29.17 |
03:53 ET | 13648 | 29.17 |
03:55 ET | 24636 | 29.275 |
03:57 ET | 41224 | 29.16 |
04:00 ET | 405269 | 29.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.9B | 9.9x | --- |
Exelixis Inc | 10.3B | 22.8x | -21.77% |
Ionis Pharmaceuticals Inc | 6.1B | -15.4x | --- |
Qiagen NV | 9.9B | 135.9x | +12.66% |
P3 Health Partners Inc | 141.5M | -0.7x | --- |
Novavax Inc | 1.4B | -3.1x | --- |
Alkermes plc is Ireland-based biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.9B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 161.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $2.95 |
Book Value | $7.20 |
P/E Ratio | 9.9x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | 9.0x |
Operating Margin | 29.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.